News - North America, Avanir Pharmaceuticals

Filter

Popular Filters

Avanir Pharma patent settlement with Wockhardt

08-09-2013

USA-based Avanir Pharmaceuticals (Nasdaq: AVNR) has entered into a settlement agreement with the US unit…

Avanir PharmaceuticalsGenericsLegalNeurologicalNorth AmericaNuedextaPatentsPharmaceuticalWockhardt

Avanir Pharma settles Nuedexta patent litigation with Actavis

03-09-2013

USA-based Avanir Pharmaceuticals (Nasdaq: AVNR) says that it has entered into a settlement agreement…

ActavisAvanir PharmaceuticalsGenericsLegalNeurologicalNorth AmericaNuedextaPatentsPharmaceutical

Avanir agrees settlement with Sandoz over Nuedexta

14-08-2013

US drugmaker Avanir Pharmaceuticals (Nasdaq: AVNR) has entered into a settlement agreement with Swiss…

Avanir PharmaceuticalsGenericsLicensingNeurologicalNorth AmericaNuedextaPharmaceuticalSandoz

Avanir to promote Merck's diabetes drug Januvia

13-08-2013

US drugmaker Avanir Pharmaceuticals (Nasdaq: AVNR) has entered into an exclusive agreement with US drug…

Avanir PharmaceuticalsDiabetesJanuviaMarkets & MarketingMerck & CoNorth AmericaPharmaceutical

Avanir in up to $110 million deal with OptiNose for migraine product

03-07-2013

US drugmaker Avanir Pharmaceuticals (Nasdaq: AVNR) has entered into an exclusive North American license…

Avanir PharmaceuticalsLicensingNeurologicalNorth AmericaOptiNosePharmaceuticalsumatriptan

Avanir sues Par and Actavis over Nuedexta patent infringement

12-08-2011

California, USA-based Avanir Pharmaceuticals (Nasdaq: AVNR) has filed law suits in the US District Court…

ActavisAvanir PharmaceuticalsGenericsLegalNeurologicalNorth AmericaNuedextaPar PharmaceuticalsPatentsPharmaceutical

Back to top